skip navigation links 
 
 Search Options 
Index | Site Map | FAQ | Facility Info | Reading Rm | New | Help | Glossary | Contact Us blue spacer  
secondary page banner Return to NRC Home Page

IN RESPONSE, PLEASE
REFER TO: M020219

February 28, 2002

MEMORANDUM TO: William D. Travers
Executive Director for Operations
FROM: Annette L. Vietti-Cook, Secretary/RA/
SUBJECT: STAFF REQUIREMENTS - MEETING WITH THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES (ACMUI), 2:00 P.M., TUESDAY, FEBRUARY 19, 2002, COMMISSIONERS' CONFERENCE ROOM, ONE WHITE FLINT NORTH, ROCKVILLE, MARYLAND (OPEN TO PUBLIC ATTENDANCE)

The Commission was briefed by the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on issues related to the development and implementation of the revised 10 CFR 35 and other issues of concern to the Committee.

The NRC staff should issue for public comment revised draft guidance documents for implementing the revised Part 35, including a stand-alone guide for diagnostic applications. The schedule should allow for resolution of public comment on the guidance document and issuance of the final guidance before the implementation date of the revised 10 CFR 35, which will be six months following publication of the final rule. The inspectors and license reviewers should also be trained to implement the revised final guidance prior to the final rule becoming effective.

The staff should also provide the Commission options for resolving the training and experience concerns raised by the ACMUI members.

  (EDO) (SECY Suspense: 3/22/02)

cc:

Chairman Meserve
Commissioner Dicus
Commissioner Diaz
Commissioner McGaffigan
Commissioner Merrifield
EDO
OGC
OCA
CFO
OIG
OPA
Office Directors, Regions, ACRS, ACNW, ASLBP (via E-Mail)
PDR

 



Privacy Policy | Site Disclaimer
Thursday, February 22, 2007